221P Peripheral T cell activation phenotype predicts clinical outcomes of atezolizumab-bevacizumab therapy in unresectable hepatocellular carcinoma

C. Kim,W.S. Lee,H. Yang,S.J. Lee, S.J. Kong, B. Kang, I. Kim, H. Kim, H. Chon

Annals of Oncology(2023)

引用 0|浏览5
暂无评分
关键词
hepatocellular carcinoma,unresectable hepatocellular carcinoma,atezolizumab-bevacizumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要